nodes	percent_of_prediction	percent_of_DWPC	metapath
Clotiazepam—GABRR3—nerve—hypothyroidism	0.105	0.108	CbGeAlD
Clotiazepam—GABRR2—nerve—hypothyroidism	0.0914	0.0937	CbGeAlD
Clotiazepam—GABRR1—nerve—hypothyroidism	0.088	0.0902	CbGeAlD
Clotiazepam—CYP2C19—urine—hypothyroidism	0.0519	0.0532	CbGeAlD
Clotiazepam—CYP3A4—urine—hypothyroidism	0.0307	0.0314	CbGeAlD
Clotiazepam—GABRG3—pituitary gland—hypothyroidism	0.0286	0.0294	CbGeAlD
Clotiazepam—GABRB1—pituitary gland—hypothyroidism	0.0221	0.0227	CbGeAlD
Clotiazepam—GABRG3—testis—hypothyroidism	0.0212	0.0217	CbGeAlD
Clotiazepam—GABRR1—testis—hypothyroidism	0.0202	0.0207	CbGeAlD
Clotiazepam—GABRP—pituitary gland—hypothyroidism	0.0198	0.0203	CbGeAlD
Clotiazepam—GABRR2—cerebellum—hypothyroidism	0.0193	0.0198	CbGeAlD
Clotiazepam—CYP2C18—liver—hypothyroidism	0.0183	0.0187	CbGeAlD
Clotiazepam—GABRE—heart—hypothyroidism	0.0181	0.0186	CbGeAlD
Clotiazepam—GABRA3—thyroid gland—hypothyroidism	0.0177	0.0181	CbGeAlD
Clotiazepam—GABRD—testis—hypothyroidism	0.0175	0.018	CbGeAlD
Clotiazepam—GABRG2—pituitary gland—hypothyroidism	0.0167	0.0171	CbGeAlD
Clotiazepam—GABRA5—testis—hypothyroidism	0.0163	0.0167	CbGeAlD
Clotiazepam—GABRD—cerebellum—hypothyroidism	0.0162	0.0166	CbGeAlD
Clotiazepam—GABRG1—cerebellum—hypothyroidism	0.0156	0.016	CbGeAlD
Clotiazepam—GABRB3—heart—hypothyroidism	0.0154	0.0157	CbGeAlD
Clotiazepam—GABRA3—testis—hypothyroidism	0.0151	0.0155	CbGeAlD
Clotiazepam—GABRE—pituitary gland—hypothyroidism	0.0151	0.0155	CbGeAlD
Clotiazepam—GABRB1—cerebellum—hypothyroidism	0.0151	0.0155	CbGeAlD
Clotiazepam—GABRA2—adrenal gland—hypothyroidism	0.0136	0.014	CbGeAlD
Clotiazepam—GABRE—adrenal gland—hypothyroidism	0.0135	0.0139	CbGeAlD
Clotiazepam—GABRB3—gonad—hypothyroidism	0.0132	0.0135	CbGeAlD
Clotiazepam—GABRE—thyroid gland—hypothyroidism	0.0131	0.0134	CbGeAlD
Clotiazepam—GABRB3—pituitary gland—hypothyroidism	0.0128	0.0132	CbGeAlD
Clotiazepam—GABRE—female gonad—hypothyroidism	0.0126	0.0129	CbGeAlD
Clotiazepam—GABRB2—testis—hypothyroidism	0.0123	0.0127	CbGeAlD
Clotiazepam—GABRB2—cerebellum—hypothyroidism	0.0114	0.0117	CbGeAlD
Clotiazepam—GABRG2—cerebellum—hypothyroidism	0.0114	0.0117	CbGeAlD
Clotiazepam—GABRE—testis—hypothyroidism	0.0112	0.0115	CbGeAlD
Clotiazepam—GABRB3—thyroid gland—hypothyroidism	0.0111	0.0113	CbGeAlD
Clotiazepam—CYP2B6—adrenal cortex—hypothyroidism	0.0108	0.011	CbGeAlD
Clotiazepam—GABRA2—cerebellum—hypothyroidism	0.0104	0.0107	CbGeAlD
Clotiazepam—CYP2B6—heart—hypothyroidism	0.0104	0.0107	CbGeAlD
Clotiazepam—GABRA1—cerebellum—hypothyroidism	0.0101	0.0103	CbGeAlD
Clotiazepam—CYP2C19—blood—hypothyroidism	0.00992	0.0102	CbGeAlD
Clotiazepam—CYP2B6—cardiovascular system—hypothyroidism	0.00983	0.0101	CbGeAlD
Clotiazepam—GABRB3—testis—hypothyroidism	0.00948	0.00972	CbGeAlD
Clotiazepam—GABRB3—liver—hypothyroidism	0.00896	0.00918	CbGeAlD
Clotiazepam—CYP2B6—gonad—hypothyroidism	0.00892	0.00914	CbGeAlD
Clotiazepam—GABRB3—cerebellum—hypothyroidism	0.00876	0.00897	CbGeAlD
Clotiazepam—CYP2B6—adrenal gland—hypothyroidism	0.00777	0.00796	CbGeAlD
Clotiazepam—CYP2B6—blood—hypothyroidism	0.00777	0.00796	CbGeAlD
Clotiazepam—CYP2C19—liver—hypothyroidism	0.00776	0.00795	CbGeAlD
Clotiazepam—CYP2B6—testis—hypothyroidism	0.00643	0.00659	CbGeAlD
Clotiazepam—CYP2B6—liver—hypothyroidism	0.00608	0.00623	CbGeAlD
Clotiazepam—CYP3A4—blood—hypothyroidism	0.00587	0.00601	CbGeAlD
Clotiazepam—CYP3A4—liver—hypothyroidism	0.00459	0.0047	CbGeAlD
Clotiazepam—GABRR1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000562	0.0233	CbGpPWpGaD
Clotiazepam—GABRR2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000536	0.0222	CbGpPWpGaD
Clotiazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000482	0.02	CbGpPWpGaD
Clotiazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000459	0.0191	CbGpPWpGaD
Clotiazepam—GABRA1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.000444	0.0184	CbGpPWpGaD
Clotiazepam—GABRG3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000441	0.0183	CbGpPWpGaD
Clotiazepam—GABRB1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000435	0.018	CbGpPWpGaD
Clotiazepam—GABRR1—Neuronal System—SLC5A7—hypothyroidism	0.00043	0.0179	CbGpPWpGaD
Clotiazepam—GABRR2—Neuronal System—SLC5A7—hypothyroidism	0.000411	0.017	CbGpPWpGaD
Clotiazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000378	0.0157	CbGpPWpGaD
Clotiazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000373	0.0155	CbGpPWpGaD
Clotiazepam—GABRB2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000371	0.0154	CbGpPWpGaD
Clotiazepam—GABRR1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000362	0.015	CbGpPWpGaD
Clotiazepam—GABRA5—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000361	0.015	CbGpPWpGaD
Clotiazepam—GABRA3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000354	0.0147	CbGpPWpGaD
Clotiazepam—GABRA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000348	0.0144	CbGpPWpGaD
Clotiazepam—GABRB3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000346	0.0144	CbGpPWpGaD
Clotiazepam—GABRR2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000345	0.0143	CbGpPWpGaD
Clotiazepam—GABRG2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00034	0.0141	CbGpPWpGaD
Clotiazepam—GABRG3—Neuronal System—SLC5A7—hypothyroidism	0.000338	0.014	CbGpPWpGaD
Clotiazepam—GABRB1—Neuronal System—SLC5A7—hypothyroidism	0.000333	0.0138	CbGpPWpGaD
Clotiazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000318	0.0132	CbGpPWpGaD
Clotiazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000309	0.0128	CbGpPWpGaD
Clotiazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000304	0.0126	CbGpPWpGaD
Clotiazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000299	0.0124	CbGpPWpGaD
Clotiazepam—GABRA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000297	0.0123	CbGpPWpGaD
Clotiazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000297	0.0123	CbGpPWpGaD
Clotiazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000291	0.0121	CbGpPWpGaD
Clotiazepam—GABRA1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000286	0.0119	CbGpPWpGaD
Clotiazepam—GABRB2—Neuronal System—SLC5A7—hypothyroidism	0.000285	0.0118	CbGpPWpGaD
Clotiazepam—GABRG3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000284	0.0118	CbGpPWpGaD
Clotiazepam—GABRB1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00028	0.0116	CbGpPWpGaD
Clotiazepam—GABRR1—Neuronal System—NEFL—hypothyroidism	0.000277	0.0115	CbGpPWpGaD
Clotiazepam—GABRA5—Neuronal System—SLC5A7—hypothyroidism	0.000277	0.0115	CbGpPWpGaD
Clotiazepam—GABRA3—Neuronal System—SLC5A7—hypothyroidism	0.000272	0.0113	CbGpPWpGaD
Clotiazepam—GABRA2—Neuronal System—SLC5A7—hypothyroidism	0.000267	0.0111	CbGpPWpGaD
Clotiazepam—GABRB3—Neuronal System—SLC5A7—hypothyroidism	0.000265	0.011	CbGpPWpGaD
Clotiazepam—GABRR2—Neuronal System—NEFL—hypothyroidism	0.000265	0.011	CbGpPWpGaD
Clotiazepam—GABRG2—Neuronal System—SLC5A7—hypothyroidism	0.00026	0.0108	CbGpPWpGaD
Clotiazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000255	0.0106	CbGpPWpGaD
Clotiazepam—GABRB2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000239	0.00993	CbGpPWpGaD
Clotiazepam—GABRA5—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000233	0.00965	CbGpPWpGaD
Clotiazepam—GABRR1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000231	0.0096	CbGpPWpGaD
Clotiazepam—GABRA3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000228	0.00947	CbGpPWpGaD
Clotiazepam—GABRA1—Neuronal System—SLC5A7—hypothyroidism	0.000228	0.00944	CbGpPWpGaD
Clotiazepam—CYP2C18—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000225	0.00934	CbGpPWpGaD
Clotiazepam—GABRA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000224	0.00931	CbGpPWpGaD
Clotiazepam—GABRB3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000223	0.00925	CbGpPWpGaD
Clotiazepam—GABRR2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000221	0.00916	CbGpPWpGaD
Clotiazepam—GABRG2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000219	0.00908	CbGpPWpGaD
Clotiazepam—GABRG3—Neuronal System—NEFL—hypothyroidism	0.000218	0.00904	CbGpPWpGaD
Clotiazepam—GABRB1—Neuronal System—NEFL—hypothyroidism	0.000215	0.0089	CbGpPWpGaD
Clotiazepam—GABRR1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000192	0.00795	CbGpPWpGaD
Clotiazepam—GABRA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000191	0.00794	CbGpPWpGaD
Clotiazepam—GABRB2—Neuronal System—NEFL—hypothyroidism	0.000183	0.00761	CbGpPWpGaD
Clotiazepam—GABRR2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000183	0.00759	CbGpPWpGaD
Clotiazepam—CYP2C18—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000182	0.00757	CbGpPWpGaD
Clotiazepam—GABRG3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000182	0.00754	CbGpPWpGaD
Clotiazepam—GABRB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000179	0.00743	CbGpPWpGaD
Clotiazepam—GABRA5—Neuronal System—NEFL—hypothyroidism	0.000178	0.00739	CbGpPWpGaD
Clotiazepam—GABRA3—Neuronal System—NEFL—hypothyroidism	0.000175	0.00726	CbGpPWpGaD
Clotiazepam—GABRA2—Neuronal System—NEFL—hypothyroidism	0.000172	0.00713	CbGpPWpGaD
Clotiazepam—GABRB3—Neuronal System—NEFL—hypothyroidism	0.000171	0.00709	CbGpPWpGaD
Clotiazepam—GABRG2—Neuronal System—NEFL—hypothyroidism	0.000168	0.00696	CbGpPWpGaD
Clotiazepam—GABRB2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000153	0.00635	CbGpPWpGaD
Clotiazepam—GABRG3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000151	0.00625	CbGpPWpGaD
Clotiazepam—GABRA5—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000149	0.00617	CbGpPWpGaD
Clotiazepam—GABRB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000148	0.00616	CbGpPWpGaD
Clotiazepam—GABRB3—BDNF signaling pathway—VAV3—hypothyroidism	0.000147	0.0061	CbGpPWpGaD
Clotiazepam—GABRA1—Neuronal System—NEFL—hypothyroidism	0.000147	0.00608	CbGpPWpGaD
Clotiazepam—GABRA3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000146	0.00606	CbGpPWpGaD
Clotiazepam—GABRA2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000143	0.00595	CbGpPWpGaD
Clotiazepam—GABRB3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000143	0.00591	CbGpPWpGaD
Clotiazepam—GABRG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00014	0.00581	CbGpPWpGaD
Clotiazepam—GABRB2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000127	0.00526	CbGpPWpGaD
Clotiazepam—GABRA5—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000123	0.00511	CbGpPWpGaD
Clotiazepam—GABRA1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000122	0.00507	CbGpPWpGaD
Clotiazepam—GABRA3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000121	0.00502	CbGpPWpGaD
Clotiazepam—GABRA2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000119	0.00493	CbGpPWpGaD
Clotiazepam—GABRB3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000118	0.0049	CbGpPWpGaD
Clotiazepam—GABRG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000116	0.00481	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—IYD—hypothyroidism	0.000114	0.00474	CbGpPWpGaD
Clotiazepam—GABRA1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000114	0.00473	CbGpPWpGaD
Clotiazepam—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000111	0.00459	CbGpPWpGaD
Clotiazepam—GABRA1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000101	0.00421	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—ATP5O—hypothyroidism	9.72e-05	0.00403	CbGpPWpGaD
Clotiazepam—CYP2C18—Biological oxidations—POMC—hypothyroidism	9.69e-05	0.00402	CbGpPWpGaD
Clotiazepam—GABRR1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	9.25e-05	0.00384	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—TPO—hypothyroidism	9.14e-05	0.00379	CbGpPWpGaD
Clotiazepam—CYP2B6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	8.97e-05	0.00372	CbGpPWpGaD
Clotiazepam—GABRR2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	8.83e-05	0.00366	CbGpPWpGaD
Clotiazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	8.36e-05	0.00347	CbGpPWpGaD
Clotiazepam—GABRR1—Transmembrane transport of small molecules—AVP—hypothyroidism	7.28e-05	0.00302	CbGpPWpGaD
Clotiazepam—GABRG3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.27e-05	0.00301	CbGpPWpGaD
Clotiazepam—GABRB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	7.16e-05	0.00297	CbGpPWpGaD
Clotiazepam—GABRR2—Transmembrane transport of small molecules—AVP—hypothyroidism	6.95e-05	0.00288	CbGpPWpGaD
Clotiazepam—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	6.78e-05	0.00281	CbGpPWpGaD
Clotiazepam—GABRB2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.12e-05	0.00254	CbGpPWpGaD
Clotiazepam—GABRA5—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.94e-05	0.00247	CbGpPWpGaD
Clotiazepam—GABRA3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.84e-05	0.00242	CbGpPWpGaD
Clotiazepam—GABRA2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.73e-05	0.00238	CbGpPWpGaD
Clotiazepam—GABRG3—Transmembrane transport of small molecules—AVP—hypothyroidism	5.72e-05	0.00237	CbGpPWpGaD
Clotiazepam—GABRB3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.7e-05	0.00236	CbGpPWpGaD
Clotiazepam—GABRB1—Transmembrane transport of small molecules—AVP—hypothyroidism	5.64e-05	0.00234	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—IYD—hypothyroidism	5.62e-05	0.00233	CbGpPWpGaD
Clotiazepam—GABRG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.59e-05	0.00232	CbGpPWpGaD
Clotiazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	5.03e-05	0.00209	CbGpPWpGaD
Clotiazepam—GABRA1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.89e-05	0.00203	CbGpPWpGaD
Clotiazepam—GABRB2—Transmembrane transport of small molecules—AVP—hypothyroidism	4.82e-05	0.002	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—ATP5O—hypothyroidism	4.78e-05	0.00198	CbGpPWpGaD
Clotiazepam—CYP2B6—Biological oxidations—POMC—hypothyroidism	4.77e-05	0.00198	CbGpPWpGaD
Clotiazepam—GABRA5—Transmembrane transport of small molecules—AVP—hypothyroidism	4.68e-05	0.00194	CbGpPWpGaD
Clotiazepam—GABRA3—Transmembrane transport of small molecules—AVP—hypothyroidism	4.59e-05	0.00191	CbGpPWpGaD
Clotiazepam—GABRA2—Transmembrane transport of small molecules—AVP—hypothyroidism	4.52e-05	0.00187	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—TPO—hypothyroidism	4.49e-05	0.00186	CbGpPWpGaD
Clotiazepam—GABRB3—Transmembrane transport of small molecules—AVP—hypothyroidism	4.49e-05	0.00186	CbGpPWpGaD
Clotiazepam—GABRG2—Transmembrane transport of small molecules—AVP—hypothyroidism	4.4e-05	0.00183	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—IYD—hypothyroidism	4.25e-05	0.00176	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—TSHB—hypothyroidism	4.23e-05	0.00176	CbGpPWpGaD
Clotiazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.08e-05	0.00169	CbGpPWpGaD
Clotiazepam—GABRA1—Transmembrane transport of small molecules—AVP—hypothyroidism	3.85e-05	0.0016	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—PIK3C2A—hypothyroidism	3.77e-05	0.00156	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—ATP5O—hypothyroidism	3.61e-05	0.0015	CbGpPWpGaD
Clotiazepam—CYP2C19—Biological oxidations—POMC—hypothyroidism	3.6e-05	0.00149	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—TPO—hypothyroidism	3.4e-05	0.00141	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—SLC5A5—hypothyroidism	3.17e-05	0.00131	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.15e-05	0.00131	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—IYD—hypothyroidism	2.55e-05	0.00106	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—ATP5O—hypothyroidism	2.17e-05	0.000901	CbGpPWpGaD
Clotiazepam—CYP3A4—Biological oxidations—POMC—hypothyroidism	2.17e-05	0.000898	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—TSHB—hypothyroidism	2.08e-05	0.000863	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—TPO—hypothyroidism	2.04e-05	0.000847	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—PIK3C2A—hypothyroidism	1.85e-05	0.000769	CbGpPWpGaD
Clotiazepam—CYP2C18—Metabolism—POMC—hypothyroidism	1.66e-05	0.000688	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—TSHB—hypothyroidism	1.57e-05	0.000652	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—SLC5A5—hypothyroidism	1.56e-05	0.000646	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	1.4e-05	0.000581	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.38e-05	0.000574	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—SLC5A5—hypothyroidism	1.18e-05	0.000488	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—TSHB—hypothyroidism	9.45e-06	0.000392	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	8.43e-06	0.00035	CbGpPWpGaD
Clotiazepam—CYP2B6—Metabolism—POMC—hypothyroidism	8.15e-06	0.000338	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—SLC5A5—hypothyroidism	7.08e-06	0.000294	CbGpPWpGaD
Clotiazepam—CYP2C19—Metabolism—POMC—hypothyroidism	6.16e-06	0.000255	CbGpPWpGaD
Clotiazepam—CYP3A4—Metabolism—POMC—hypothyroidism	3.7e-06	0.000154	CbGpPWpGaD
